Posted by AGORACOM-JC
at 9:25 AM on Monday, January 18th, 2021
Announced today that the CEO of the Company, Cameron Chell, will be featured on “Making Money with Charles Payne” on Fox Business.
Segment on Fox Business will focus on Draganfly’s recent announcements in relation to Draganfly’s Varigard spraying program which provides 24-hour sequestration and kill efficacy against pathogens including COVID-19 in a single application.
Los Angeles, CA, Jan. 18, 2021 —Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“ Draganfly ” or the “ Company ”), an award-winning, industry-leading manufacturer and systems developer, announced today that the CEO of the Company, Cameron Chell, will be featured on “Making Money with Charles Payne” on Fox Business.
The segment on Fox Business will focus on Draganfly’s recent announcements in relation to Draganfly’s Varigard spraying program which provides 24-hour sequestration and kill efficacy against pathogens including COVID-19 in a single application.
“I am super excited to share our story with Charles Payne on Fox Business,” said Cameron Chell, CEO Draganfly. “The surface disinfecting market size is surging and expected to reach $1.5 billion by 2027, due in part to the requirement to disinfect large areas like stadiums. Varigard ™ has already established a technical leadership position and we look forward to providing the most advanced drones and services to their customers.”
Cameron Chell’s segment on Fox Business with Charles Payne will air at 2PM ET on Monday, January 18.
Posted by AGORACOM-JC
at 7:14 AM on Monday, January 18th, 2021
Frederic Fasano named President and COO
Steve Saviuk continues as CEO and becomes Vice-Chairman of the Board of Directors
MONTREAL , Jan. 18, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today the appointment of Mr. Frederic Fasano to the newly created position of President and Chief Operating Officer, effective January 18th , to augment its senior leadership team and support expansion of Valeo’s commercial activities. Mr. Fasano has also been elected to the Company’s Board of Directors effective as of today.
“It gives me true pleasure to welcome Frederic to the Valeo executive team in this important new role. He possesses extensive International pharmaceutical experience and his management skills are well suited to helping us build a leading innovative pharmaceutical company with a deep commitment to our selected therapeutic areas of focus”, said Steve Saviuk, CEO. “This increase in management depth, coupled with our solid foundation of products and people, positions us well for the dynamic growth we foresee in the coming years.”
Posted by AGORACOM-JC
at 4:15 PM on Thursday, January 14th, 2021
Announced the successful completion of a large-scale production of exosomes
Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the CLX Therapy development process.
Innocan managed to perform the production of trillions of exosomes in a short period of time in a 3-dimensional bioreactor, and that may lead to economic large scale exosome production for the CLX.
This achievement is expected to pave the way for larger tests and studies.
Herzliya, Israel and Calgary, Alberta–(January 14, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan“), is pleased to announce the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the CLX Therapy development process. Innocan managed to perform the production of trillions of exosomes in a short period of time in a 3-dimensional bioreactor, and that may lead to economic large scale exosome production for the CLX. This achievement is expected to pave the way for larger tests and studies.
“Innocan is now one of a few public companies in the exosome’s science field. Although we are still in the development stage of the CLX platform, large scale exosome production capabilities are a significant proof of advantage and capability for Innocan, as part of the path to commercialization,” said Iris Bincovich, founder and CEO of Innocan.
Innocan Pharma together with Tel Aviv University, Prof. Offen and his team, are developing a new revolutionary cell therapy – based technology, loaded with CBD (Cannabidiol), designed to target coronavirus infected lung cells and central nervous system diseases. The CLX Therapy holds the potential to provide a highly synergistic effect of anti-inflammatory properties and help in the recovery of infected lung cells. This product is planned to act as a “guided missile” to the infected lungs, combining the cell healing properties of exosomes and the anti-inflammatory properties of CBD.
Posted by AGORACOM-JC
at 12:14 PM on Thursday, January 14th, 2021
Commercial launch to impact first half 2021 revenue
$30 million forecasted annual peak sales
8 years of proven in-market safety Internationally
Low molecular weight heparin increasingly used to prevent COVID-19 driven complications
“The regulatory approval of Redesca is a significant corporate milestone for Valeo and also great news for the Canadian healthcare system. Mandatory use of biosimilars is increasingly being adopted across the country and is expected to help provide significant savings to provincial healthcare plans”, said Steve Saviuk , President and CEO. “With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives”.
Posted by AGORACOM-JC
at 8:04 AM on Thursday, January 14th, 2021
Most of us know drones as cool toys flying around the neighbourhood, or perhaps even as simple commercial applications for things like real estate videos.
But the fact of the matter is that drone usage is about to go parabolic with huge corporations now testing ways to:
Use drones to provide Internet connections in remote locations.
Use drones to collect crowd data.
….. And there’s even a start-up that’s using drones to deliver tacos to your door.
In short, the drone industry is booming in ways people can’t imagine because the industry is shifting from the drones (hardware) to data … and one company is already ahead of the shift … DraganFly (DFLY: CSE) (DFLYF:OTCQB) (3U8:FSE)
DraganFly is an award-winning drone manufacturer and technology developer that is actually delivering some pretty incredible achievements, milestones and even history:
Established in 1998 DFLY is considered the oldest commercial drone company in the world
Built the first drone that saved a life
Boasts the first drone to be inducted into the Smithsonian National Air & Space Museum
Developing a Vaccine Drone Delivery Payload System (it’s way more complicated than just transporting vaccines)
Detect infectious conditions in a person from a distance of 190 feet
Conduct phenotyping, data collection and analysis by the USDA
With all of this under the Company’s belt, it’s easy to see why CEO Chell believes DFLY will become one of the top 3 drone companies in the world and why they have now begun the process of listing on NASDAQ.
If you believe in the massive parabolic growth in the use of drones for almost everything we do in this world, or are just learning, then watch / listen to this powerful interview with Draganfly CEO and Chairman, Cameron Chell.
Posted by AGORACOM-JC
at 9:28 AM on Wednesday, January 13th, 2021
Announced that the Company has started the process of preparing for a listing of its common shares on the NASDAQ Capital Market
Company has engaged a New York based investment bank to begin the NASDAQ listing process.
The NASDAQ is a mark of achievement and stature for qualified companies.
Listed companies must meet financial and liquidity requirements and satisfy corporate governance and disclosure requirements on both an initial and continuing basis.
Los Angeles, CA., Jan. 13, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, today announced that the Company has started the process of preparing for a listing of its common shares on the NASDAQ Capital Market (“NASDAQ”).
The Company has engaged a New York based investment bank to begin the NASDAQ listing process. The NASDAQ is a mark of achievement and stature for qualified companies. Listed companies must meet financial and liquidity requirements and satisfy corporate governance and disclosure requirements on both an initial and continuing basis.
The listing of the Company’s common shares on the NASDAQ is subject to the approval of the NASDAQ and the ability of the Company to satisfy all applicable listing and regulatory requirements. While the Company intends to satisfy all of the applicable listing criteria, there is no assurance that the NASDAQ will approve the Company’s application or that the Company will complete the listing as proposed.
Draganfly management believes up-listing to NASDAQ will:
Provide additional opportunities to attract institutional and retail investors, allowing the Company to broaden its investor base in the United States and internationally.
Increase the visibility of the Company, its growth strategy, accomplishments and results to date.
Embark on an aggressive M&A strategy.
Increase liquidity of the Company’s common shares; and
Raise the Company’s overall profile and ultimately enhance shareholder value.
“Today’s announcement is a significant milestone in our efforts to build Draganfly into an industry-leading manufacturer and systems developer,” said Cameron Chell, CEO of Draganfly. “In addition to increasing our visibility in the marketplace, the up-listing should improve the liquidity of our stock, broaden our institutional shareholder base and augment long-term shareholder value.”
Draganfly had significant growth in 2020 in regard to its customer acquisitions, partnerships, product development and the growth of the Company’s sales pipeline. Here are some highlights from the past twelve months:
Launched the Vital Intelligence Smart Vital COVID-19 assessment platform that can automatically detect elevated body temperature and, with voluntary consent, heart rate, respiratory rate and O2 saturation, all from a camera that takes seconds to capture the information.
Launched a telehealth app for third party developers to integrate the Smart Vital technology with their own apps and devices.
Achieved 200%+ year-over-year revenue growth with 50% quarter-over-quarter revenue growth in the third quarter (1) ;
Launched two additional flight services divisions in the mining and facility management industries (which includes providing the delivery via Draganfly’s patented drone technologies of the Varigard pathogen and virus surface sanitizer);
Exclusive worldwide distributor of Aerovironment’s (NASDAQ: AVAV) Quantix Mapper RPAS;
Selected by Coldchain Technology Services, LLC to immediately develop and provide flight services of a robust vaccine delivery payload for use in critical regions for drone delivery of the COVID-19 vaccine; and
Awarded new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
Posted by AGORACOM-JC
at 8:47 AM on Wednesday, January 13th, 2021
Financial Service Agreement for US listings, registrations, and potential transactions
Announced today that it has retained Houston, Texas based Entoro Capital, LLC , a technology-enabled global investment bank and broker-dealer, to provide a range of Financial Advisory Services in the United States of America.
KABN NA and Entoro will together be reviewing KABN NA’s proposed upgraded OTC Markets listing, and in the future, potential, but not assured, U.S. based transactions including, but not limited to a potential Reg A+ offering, registrations, and listing opportunities.
Entoro will also use its network to introduce KABN North America to potential business opportunities.
TORONTO, ON and HOUSTON, TX / January 13, 2021 / KABN Systems NA Holdings Corp. (CSE:KABN)(OTC PINK:TRWRF)(FRA:4T51) (the “Company“, “KABN North America” or “KABN NA“) (www.kabnsystemsna.com), a North American Fintech solutions company specializing in empowering individuals to manage, control and generate value from their biometrically-verified Self Sovereign Identity (“SSI”) through its Liquid Avatar (www.liquidavatar.com) platform, announces today that it has retained Houston, Texas based Entoro Capital, LLC (“Entoro”), a technology-enabled global investment bank and broker-dealer, to provide a range of Financial Advisory Services in the United States of America.
KABN NA and Entoro will together be reviewing KABN NA’s proposed upgraded OTC Markets listing, and in the future, potential, but not assured, U.S. based transactions including, but not limited to a potential Reg A+ offering, registrations, and listing opportunities. Entoro will also use its network to introduce KABN North America to potential business opportunities.
Entoro provides advice and services to a wide range of established and growth-oriented businesses around the world. Their experienced professionals offer deep sector expertise across a full range of services in investment banking, equities, and fixed income.
While KABN NA is not proposing any immediate offerings in the US, nor are any assured, Entoro is also a leader in the Regulation A+ capital raise marketplace through its FINRA-registered broker-dealer subsidiary, Entoro Securities, having developed strong retail investor distribution relationships to better leverage the registration exemption for its clients. As part of its service programs, in addition to any traditional offering process, Entoro will be using OfferBoard® to automate any future US-based transactions. OfferBoard® is Entoro’s high-tech, investor portal that provides flexibility, convenience, transparency, and security for investors while increasing engagement and streamlining the entire process. OfferBoard® also allows accredited and qualified investors to review multiple project details and investment criteria with confidence after signing a non-disclosure agreement.
“We have known the world-class investment and management team at Entoro for a number of years and together, we have been looking for the right time and opportunity to work together” said David Lucatch, CEO KABN. “With the open-beta launch of Liquid Avatar just weeks away and having successfully completed our Canadian offerings, in part with Mackie Research this past December, we are excited to bring Entoro on board to help us create awareness, business opportunities, financial advisory services and in the future, potential capital initiatives in the U.S.”
Posted by AGORACOM-JC
at 1:15 PM on Tuesday, January 12th, 2021
Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tablets and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drones.
“We are excited to be exhibiting at CES this year,” said Cameron Chell, CEO of Draganfly. “And we are extremely excited to be holding live events throughout the run of CES.”
Los Angeles, CA, Jan. 12, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that it has scheduled a series of live events January 13-14 during their participation at the Consumer Electronics Show.
Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tablets and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drones.
“We are excited to be exhibiting at CES this year,” said Cameron Chell, CEO of Draganfly. “And we are extremely excited to be holding live events throughout the run of CES.”
All live events are accessible to both participants of CES and external guests.
January 13 1:30PM PST Live Demo: Draganfly’sVital Intelligence Assessment Technology
Cameron Chell will be joined by Derek Anderson, CEO of Stamina Inc., author,philanthropist, NCAA & NBA Champion, and Jack Chow, Former US Ambassador and Assistant Director-General of the World Health Organization onInfectious Disease and Draganfly Advisor as well as Dr. Javaan Chahl, Defensescience and technology chair at the University of South Australia and ChiefScientist for Draganfly’s Vital Intelligence for a discussion about getting American’sback to work, school and play again. We will also provide a demo of our vitalintelligent technology. Link to register.
January 14 1130AM PST Discussion: How to get our athletes back in the game
Join Cameron Chell, CEO of Draganfly in a one-on-one conversation with DerekAnderson NBA, NCAA champion and Draganfly board advisor as they discuss thehot topic of how to make our sports arenas, stadiums and fields safe for the sportsteams, employees, staff and the fans. Link to register.
January 14 130PM PST Discussion: Draganfly + Knightscope robots
Posted by AGORACOM-JC
at 9:21 AM on Tuesday, January 12th, 2021
Both KABN North America (KABN:CSE) and ImagineAR (IP:CSE / IPNFF:OTCQB) are incredibly disruptive and on the cusp of unstoppable trends, which makes them both explosive but also so new that investors still need to wrap their minds around each of them, let alone both of them together. The good news is that CEO’s from both companies (David Lucatch KABN and Alen Paul Silverrstieen ImagineAR) have sat down with us to explain why their combination is the way all of us will be controlling and profiting from our online identities in the near future.
Before watching the video, here is a little about what you need to know about each company.
KABN – Solves the major problem around our online identities and data. Through Liquid Avatar they provide each one of us with the power to manage and monetize our digital identity, which is an unstoppable trend as both a natural evolution of the web, as well as, legislation forcing big platforms to no longer share and profit from our personal online data.
IMAGINEAR – As the name implies, ImagineAR is an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns with no programming or technology experience. AR is also an unstoppable trend – but don’t take our word for it.
Apple CEO Tim Cook stated “AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”
The AR market is expected to grow to $200 Billion by 2025 from just $3.5 billion in 2017. .
Now you know why the combination of these two companies is so powerful and well worth your while to watch, listen and learn about what they are going to do. The future is coming, so you might as well see it coming first.
